Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) Change In Receivables : ₽0.0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Change In Receivables?

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's change in receivables for the quarter that ended in Dec. 2023 was ₽0.0 Mil. It means Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Accounts Receivable stayed the same from Sep. 2023 to Dec. 2023 .

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's change in receivables for the fiscal year that ended in Dec. 2023 was ₽0.0 Mil. It means Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Accounts Receivable stayed the same from Dec. 2022 to Dec. 2023 .

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Accounts Receivable for the quarter that ended in Dec. 2023 was ₽12.0 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Days Sales Outstanding for the three months ended in Dec. 2023 was 15.67.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's liquidation value for the three months ended in Dec. 2023 was ₽-629.8 Mil.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Change In Receivables Historical Data

The historical data trend for Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Change In Receivables Chart

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-41.52

-11.99

76.01

29.03

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₽0.0 Mil.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	12.04	/	70.132	*	91
=	15.67

2. In Ben Graham's calculation of liquidation value, Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's accounts receivable are only considered to be worth 75% of book value:

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	196.066	-	836.931	+	0.75 * 12.04	+	0.5 * 4.147
=	-629.8

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Change In Receivables Related Terms

Thank you for viewing the detailed overview of Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

St. Gubkina, 3, Building 1, Floor 1, Pom. I, r. 24, Moscow, RUS, 119333

Website

https://www.gemabank.ru

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC, through its subsidiary, is engaged in offering personal storage of cord blood stem cells in Russia and Eastern Europe. The services provided by the company include Cord Blood Cell Preservation, Program for the treatment of Cerebral Palsy, Cord Blood DNA isolation and Umbilical cord tissue among others.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) Headlines

No Headlines